🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Looking forward to the PRIME-ROSE project meeting and the Opening Symposium of the PCM4EU Spring Academy April 3. The Opening Symposium is accessible also digitally - check out the attachment for program and link to the streaming: matrix-fkb.no/en/pcm4eu-news…

The PCM4EU Spring Academy Opening Symposium hosted by IPO Porto is addressing precision cancer medicine, focussing both on the past, the present & the future. Thanks to all the speakers for excellent presentations and discussions!

Are you looking for a PhD position and are interested in precision cancer medicine? Open position in Åslaug Helland’s group at OUH. The position is connected to a new clinical trial MATRIX-RARE: 2411.webcruiter.no/Main2/Recruit/…

PCM4EU’s white paper on molecular assays and molecular tumor boards for trial inclusion has been published in Journal of Internal Medicine👏 - many congratulations: matrix-fkb.no/en/pcm4eu-news…

Warm congratulations to Kjetil Tasken on receiving the Excellent Researcher Award at Oslounivsykehus 👏👏matrix-fkb.no/no/aktuelt/kje…

The next Acta Oncologica Nordic Precision Cancer Medicine Symposium will take place in Oslo 15-17 September 2025 - save the date! A special NPCM symposium collection originating from the NPCM2023 conference has now been published. For more information: matrix-fkb.no/en/news/upcomi…

Er du interessert i presisjonsmedisin og vil bli vår nye forskningskoordinator? Vi søker nå en prosjektkoordinator for to nasjonale kliniske studier: IMPRESS-Norway og MATRIX-RARE. Søknadsfrist 18. august: 2411.webcruiter.no/Main2/Recruit/…

Norwegian Cancer Symposium, Sept 9-10, 2024, celebrating 70 years of #CancerResearch at Institute for Cancer Research, Oslounivsykehus, starts with >430 participants, speakers & invited guests. Look forward to talks by 15 invited speakers, 8 short talk speakers, and 118 posters.

The Norwegian Cancer Symposium 2024 is marking the 70th anniversary of Institute for Cancer Research at Oslounivsykehus. Keynote speaker #DouglasHanahan kicked-off the scientific program with an excellent talk about Hallmarks of Cancer 2024.

Thank’s to all the organizers for two fantastic days at the Norwegian Cancer Symposium, marking the 70th aniversary of the ICR! Inspiring talks, good discussions, two vibrant poster sessions with almost 200 posters as well as delicious food👏👏👏

Nytt håp for #Brystkreftpasienter med hjernemetastaser! Studieresultater viser at Enhertu gir sterk effekt hos HER2-positive pasienter. Med godkjenning fra Beslutningsforum kan behandlingen tas i bruk umiddelbart. #Onkologi #Kreftforskning #ESMO2024 bit.ly/3XrImI5

We congratulate @SigridSkanland and the CLL-OUTCOME consortium on receiving funding from #EP PerMed👏: matrix-fkb.no/en/news/the-cl… ous-research @Oslo universitetssykehus Kjetil Tasken Åslaug Helland Hege Russnes

Lær mer om pasientsentrert behandling innen kreftbehandling og satsningen MyPath: oslo-universitetssykehus.no/om-oss/ekspert… stein Kaasa Tonje Lundeby

#Johnson&Johnson joins #IMPRESS-Norway Åslaug Helland Kjetil Tasken Hege Russnes ous-research Anne Sveaass PRIME-ROSE PCM4EU matrix-fkb.no/en/news/johnso…

The international lung cancer day, started with a focus from the TV-show "GodMorgenNorge". Despite important improvements for subgroups of patients, lung cancer is still a disease with a poor prognosis, and more research is needed. Lungekreftforeningen

We congratulate all the 27 cancer researchers that today received funding from the Norwegian Cancer Society 👏 We are excited that two projects connected to MATRIX are funded and congratulate Åslaug Helland, Kjetil Tasken and their research teams: matrix-fkb.no/en/news/two-ma…

Vi er glade for å kunne kunngjøre at Novartis er første legemiddelselskap som offisielt er inne i vår nye forsker-initierte studie MATRIX-RARE👏 Les mer om studien og samarbeidet: matrix-fkb.no/no/aktuelt/nov… Åslaug Helland Kjetil Tasken Oslounivsykehus #TarjeBergdahl #Novartis

Stort engasjement på Symposium om offentlig tjenesteinnovasjon på Det Norske Videnskaps-Akademi denne uken. Hva kjennetegner offentlig tjenesteinnovasjon? Hvordan sette i gang endringsprosesser? Takk til Kjetil Tasken for en fantastisk dag👏 matrix-fkb.no/no/aktuelt/sto…

#HSØ har tradisjonen tro delt ut de beste førjulsgaver i form av tildelinger til nye forskningsprosjekter. Vi gratulerer Kjetil Tasken og Jon Amund Kyte med to av disse tildelingene: matrix-fkb.no/no/aktuelt/nye…

Today we are writing in Aftenposten about the new #protontherapy centers soon to open Oslounivsykehus and Haukeland. Read to find out why the cyclotron at the Radiumhospital is named «Ellen Gleditsch». Det Norske Videnskaps-Akademi #EirikMalinen #MarianneGuren Universitetet i Oslo e-avis.aftenposten.no/shared/article…